Site-specific chemoenzymatic protein modifications
AssigneeNovartis AG
InventorsAimee Usera, Zachary Robinson, Jennifer Cobb
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functionalized proteins may be used for study or therapeutic uses.
Claims17
A method for modifying a protein, comprising:
- providing a target protein having at least one lysine residue;
- contacting the target protein with a modifying compound having the formula
- R1-(Leu)x-Gln-(Gly)y-(A-W—B—R2)z in the presence of a microbial transglutaminase to form a modified protein;
- wherein x is 0 or 1;
- y is 0 or 1;
- z is 0 or 1;
- R1 is selected from the group consisting of:
- acetyl,
- wherein R4 is selected from —H, —N3, and
- W is selected from:
- C1-C6 linear or branched alkyl or polyethylene glycol having a molecular weight of between about 40 and about 80,000 amu;
- A is absent or selected from —O—, —NH—, and —S—;
- B is absent or selected from —O—, —C(O)—, —NH—, —C(O)NH—, —NHC(O)—, —NHC(O)O—, —OC(O)NH—, —OC(O)O—, —C═N(OH)—, —S(O2)—, —NHS(O2)—, —S(O2)NH—, —S(O)—, —NHS(O)—, —S(O)NH—;
- —C(O)O—, —OC(O)—, —S—, ═NH—O—, ═NH—NH— and ═NH—N(C1-C20alkyl)-;
- R2 is selected from the group consisting of:
- a fatty acid, linear or branched C1-C3 alkyl-N3, cyclooctynyl, fluorophore, polysaccharide, —CH(OCH3)2,
- each n is an integer independently selected from 0 to 6;
- each Q is selected from H and NO2.
2-97. (canceled)
A conjugate of a compound of the formula R1-(Leu)x-Gln-(Gly)y-A-W—B—R2 wherein x is 0 or 1 is 0 or 1 z is 0 or 1;
- R1 is selected from the group consisting of:
- acetyl,
- wherein R4 is selected from —H, —N3, and
- W is selected from:
- C1-C6 linear or branched alkyl or polyethylene glycol having a molecular weight of between about 40 and about 80,000 amu;
- A is absent or selected from —O—, —NH— and —S—;
- B is absent or selected from —O—, —C(O)—, —NH—, —C(O)NH—, —NHC(O)—, —NHC(O)O—, —OC(O)NH—, —OC(O)O—, —C═N(OH)—, —S(O2)-, —NHS(O2)—, —S(O2)NH—, —S(O)—, —NHS(O)—, —S(O)NH—;
- —C(O)O—, —OC(O)—, —S—, ═NH—O—, ═NH—NH— and ═NH—N(C1-C20alkyl);
- R2 is selected from the group consisting of:
- a fatty acid, linear or branched C1-C3 alkyl-N3, cyclooctynyl, fluorophore, polysaccharide, —CH(OCH3)2,
- each n is an integer independently selected from 0 to 6;
- and each Q is selected from H and —NO2.
A conjugate of a compound of claim 97.
A therapeutic protein comprising a compound of claim 96.
A therapeutic protein comprising a compound of claim 97.
An imaging agent comprising a compound of claim 96.
An imaging agent comprising a compound of claim 97.
A labeling tool comprising a compound of claim 96.
A labeling tool comprising a compound of claim 97.
The conjugate of claim 97, wherein R1 is selected from the group consisting of:
Dependencies are inferred from the claim text.